Mystic Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Mystic Asset Management's PFE Position: Q1 2026 in Review
Mystic Asset Management increased its Pfizer (PFE) stake by 0.02% in Q1 2026, buying an estimated $745 and bringing the position to 179,704 shares worth $5.05M. The position accounts for 1.17% of the portfolio, ranked #20.
Mystic Asset Management first reported a position in PFE in Q4 2021 and has held it in 18 quarters since. The position peaked at $5.59M in Q3 2025. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Mystic Asset Management held 179,704 shares of Pfizer worth $5.05M as of Q1 2026.
- Mystic Asset Management bought 28 Pfizer shares in Q1 2026, an estimated $745.
- Pfizer made up 1.17% of Mystic Asset Management's portfolio in Q1 2026, its #20 holding.
- Mystic Asset Management first reported a position in Pfizer in Q4 2021 and has held it in 18 quarters since.
- Mystic Asset Management's Pfizer position peaked at $5.59M in Q3 2025.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Mystic Asset Management's 13F filing for Q1 2026, filed 8 May 2026.